Top Markets
Coin of the day
MedTech Acquisition Corporation MedTech Acquisition Corporation

MedTech Acquisition Corporation

MTAC
Rank in Stocks #15409
MedTech Acquisition Corporation currently has no significant active business... MedTech Acquisition Corporation currently has no significant active business operations. The firm's stated intention is to pursue and finalize a business combination — which could involve a merger, stock exchange, asset acquisition, or other forms of corporate restructuring — with one or more enterprises in the U.S. healthcare industry. Established in 2020, its corporate base is situated in Greenwich, Connecticut.
Share Price
$11.34
Last synced: 2023-08-10
Market Cap
$354.38M
Change (1 day)
18.67%
Change (1 year)
0.00%
Country
US
Trade MedTech Acquisition Corporation (MTAC)
P/E ratio for MedTech Acquisition Corporation (MTAC)
P/E ratio as of 2026 TTM: 0
According to MedTech Acquisition Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for MedTech Acquisition Corporation from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.